In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ardana raises £20mm in Series B round; adds another £9mm

Executive Summary

Ardana Bioscience Ltd. (reproductive health treatments) brought in £20mm ($32.4mm) in its Series B round led by Techno Venture Management. New investor ISIS Equity Partners (the private equity arm of ISIS Asset Management) participated along with existing shareholders Merlin Biosciences, MVM Ltd., 3i, ABN-AMRO, and Green Highlander.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies